← All trials
NCT04681170
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Sep 30, 2023
- First posted
- Dec 23, 2020
- Last posted
- Dec 23, 2020
- Enrollment
- 45
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Amryt Research LimitedLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.